ICAM1 and cancer: Chen et al. (2013) determined that pathological concentrations of galectin‐3 in patients with cancer increased the expression of endothelial cell surface adhesion molecules such as E‐selectin and ICAM‐1, which resulted in enhanced endothelial cell activities in metastasis.